Fusion Finance Ltd. Share Price

Zydus Affiliate Scales Optogenetics Platform

The biopharmaceutical landscape is witnessing a significant technological leap as Zylidac Bio LLC, a wholly owned biologics contract development and manufacturing organisation of Zydus Lifesciences Limited joins forces with the biotechnology innovator Prolific Machines. This strategic partnership is specifically structured to scale Prolific's proprietary, light-controlled biomanufacturing technology from early-stage cell line development all the way up to commercial Good Manufacturing Practice (GMP) standards. By combining cutting-edge biotechnology with industrial-scale infrastructure, the two Emeryville, California-based entities intend to introduce a streamlined, end-to-end drug substance production pathway for clients globally. Prolific Machines has developed a bespoke photomolecular platform that leverages light and optogenetics to directly control gene and protein expression within living cell lines. Traditional biomanufacturing relies heavily on chemical triggers to manage cellular behavior, which can often result in unpredictable yields or poor process control. Prolific's method introduces artificial intelligence (AI) process data, hardware illumination tools, and advanced analytics to optimize outputs. The efficiency of this light-based system has already yielded impressive milestones, including a record productivity level of 21 g/L for monoclonal antibodies (mAbs) and up to three-fold titer increases for structurally intricate biological formats. This approach is particularly effective for multi-specific antibodies, fusion proteins, and complex cytokines that are historically difficult to express.

FIIs & DIIs Turn Buyers After Market Mayhem

FIIs & DIIs Turn Buyers After Market Mayhem — US Markets Rally, Earnings in Focus Market Outlook: Recovery Attempt Likely | Institutional Buying Provides Support | Selective Earnings Opportunities GLOBAL CUES: US MARKETS CLOSE HIGHER Wall Street ended Wednesday's session on a positive note, supported by strong corporate earnings and gains in technology stocks. --->FII–DII DATA: BOTH INSTITUTIONS BUY IN THE CASH MARKET Institutional flow data for Wednesday, 21 October 2026, shows buying by both foreign and domestic institutions during a volatile period for the market. Institutional activity Net flow FII cash market +₹1,022.32 crore DII cash market +₹1,614.32 crore FII index futures +₹255.90 crore FII index options −₹9,158.54 crore FII stock futures +₹2,548.66 crore FII stock options +₹283.34 cror --->BANK NIFTY: 54,580 SUPPORT, 55,000 UPSIDE TRIGGER Bank Nifty remains the key index to monitor as the market attempts to stabilise after recent selling pressure. Key levels for today's session Immediate support: 54,580 Recovery trigger: 55,000 --> STRONG RESULTS !ETERNAL ADANIGREEN INDHOTEL --->FUSION CX LISTING TODAY Fusion CX is scheduled to list on the NSE and BSE on Thursday, 22 October 2026. --->BOTTOM LINE After recent market turmoil, Wednesday's institutional data offers an encouraging development: both FIIs and DIIs were net buyers in the cash market. Positive US market performance adds support, while strong quarterly results from Eternal, Indian Hotels and Adani Green provide stock-specific catalysts. However, a single session of buying does not establish a durable market bottom.

Fusion CX IPO and growth analysis of company

Fusion CX is launching its IPO from October 14 to October 16, set at a price of 289 per share. The company seeks to raise 4,200 crore in valuation, with 500 crore earmarked for debt reduction and expansion. The business operates as a digital customer service provider across 13 countries in 28 languages. The core value proposition lies in the deployment of its AI tool, Arya, which reduces dependency on human resources, thereby expanding EBITDA margins from 15-16% to 18%. This shift toward AI-led service models suggests potential for future margin expansion toward 25%. While the company faces regulatory risk—specifically potential government mandates requiring disclosure of AI-human interaction—its strong client retention and fixed-fee model provide stability. With a forward PE ratio projection of roughly 21x for this year and potentially 13x in two years, the valuation appears attractive relative to its growth trajectory. Investors should monitor how effectively the company executes its expansion plans and manages the regulatory landscape. I am positive on both short-term listing gains and long-term prospects. Other information is for educational purposes only. Final investment decisions should be based on the investor's own research and, where appropriate, guidance from a SEBI-registered Investment Adviser.

Muthoot Microfin AUM rises 22% to ₹15,323 crore.

Muthoot Microfin Limited

Fusion Finance Designated Person Acquires Shares

HCLTech Expands CrowdStrike Partnership for Enterprise AI

HCL Technologies has deepened its strategic alliance with CrowdStrike by integrating CrowdStrike Falcon Guardian with HCLTech’s AI Security and Resilience services. This collaboration will be delivered through HCLTech’s global Cybersecurity Fusion Centers to comprehensively secure AI applications, models, datasets, and endpoints. Key Highlights: Advanced AI Security: Transitions the service offering from standard endpoint protection to advanced, model-specific AI security, building on the Continuous Threat Exposure Management services launched in March 2026. Strong Q1 FY27 Financials: HCLTech reported robust growth, with consolidated revenue rising 13.9% YoY to ₹34,579 crore and net profit surging 20.4% YoY to ₹4,626 crore, while maintaining a healthy EBIT margin of 16.86%. Strategic Rationale: Value Chain Ascent: This integration acts as a high-margin differentiator, elevating HCLTech from traditional IT outsourcing to specialized, high-yield security, advisory, and AI governance services. Capturing Enterprise Budgets: As organizations rapidly adopt Generative AI, this partnership positions HCLTech to capture growing corporate budgets dedicated to securing Large Language Model (LLM) deployments and protecting sensitive enterprise data. Market Outlook: Cybersecurity remains a highly resilient revenue stream for global IT services amid broader enterprise spending caution. This strategic alliance will help HCLTech maintain premium billing rates, defend its EBIT margins, and solidify its reputation as a trusted partner for secure, enterprise-grade AI transformation.